Skip to Main Content

Paper Details

Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering.
Sci Adv
18
2023
CAR, CAR-NK cell, CAR-NK cells, CAR19, CAR19/IL-15 NK cells, IL-15, NK cell clusters, NK cells, lymphoma, natural killer (NK) cells, patient, single, tumor
Author NameAffiliation
Jens G LohrDana-Farber Cancer Institute
Jens G LohrBroad Institute of MIT and Harvard
Jens G LohrHarvard Medical School
Ken ChenThe University of Texas MD Anderson Cancer Center
  • 1 - 4

Datasets

Release 1.2